| BET bromodomain inhibition as a therapeutic strategy to target c-Myc JE Delmore, GC Issa, ME Lemieux, PB Rahl, J Shi, HM Jacobs, E Kastritis, ... Cell 146 (6), 904-917, 2011 | 3118 | 2011 |
| Initial genome sequencing and analysis of multiple myeloma MA Chapman, MS Lawrence, JJ Keats, K Cibulskis, C Sougnez, ... Nature 471 (7339), 467-472, 2011 | 1716 | 2011 |
| Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma JJ Keats, R Fonseca, M Chesi, R Schop, A Baker, WJ Chng, S Van Wier, ... Cancer cell 12 (2), 131-144, 2007 | 1229 | 2007 |
| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1186 | 2009 |
| Multiple myeloma: evolving genetic events and host interactions WM Kuehl, PL Bergsagel Nature Reviews Cancer 2 (3), 175-187, 2002 | 1138 | 2002 |
| Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo, MS Lawrence, D Auclair, ... Cancer cell 25 (1), 91-101, 2014 | 1109 | 2014 |
| Multiple myeloma: increasing evidence for a multistep transformation process M Hallek, P Leif Bergsagel, KC Anderson Blood, The Journal of the American Society of Hematology 91 (1), 3-21, 1998 | 1035 | 1998 |
| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 958 | 2012 |
| Genetics and cytogenetics of multiple myeloma: a workshop report R Fonseca, B Barlogie, R Bataille, C Bastard, PL Bergsagel, M Chesi, ... Cancer research 64 (4), 1546-1558, 2004 | 940 | 2004 |
| Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma PL Bergsagel, WM Kuehl, F Zhan, J Sawyer, B Barlogie, ... Blood 106 (1), 296-303, 2005 | 883 | 2005 |
| Frequent translocation t (4; 14)(p16. 3; q32. 3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 M Chesi, E Nardini, LA Brents, E Schröck, T Ried, WM Kuehl, ... Nature genetics 16 (3), 260-264, 1997 | 854 | 1997 |
| Advances in biology of multiple myeloma: clinical applications T Hideshima, PL Bergsagel, WM Kuehl, KC Anderson Blood 104 (3), 607-618, 2004 | 831 | 2004 |
| Clonal competition with alternating dominance in multiple myeloma JJ Keats, M Chesi, JB Egan, VM Garbitt, SE Palmer, E Braggio, ... Blood, The Journal of the American Society of Hematology 120 (5), 1067-1076, 2012 | 782 | 2012 |
| The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee E Campo, ES Jaffe, JR Cook, L Quintanilla-Martinez, SH Swerdlow, ... Blood, The Journal of the American Society of Hematology 140 (11), 1229-1253, 2022 | 754 | 2022 |
| Molecular pathogenesis and a consequent classification of multiple myeloma PL Bergsagel, WM Kuehl Journal of clinical oncology 23 (26), 6333-6338, 2005 | 731 | 2005 |
| Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling S Vallabhapurapu, A Matsuzawa, WZ Zhang, PH Tseng, JJ Keats, ... Nature immunology 9 (12), 1364-1370, 2008 | 730 | 2008 |
| The t(4;14) Translocation in Myeloma Dysregulates Both FGFR3and a Novel Gene, MMSET, Resulting in IgH/MMSET Hybrid Transcripts M Chesi, E Nardini, RSC Lim, KD Smith, WM Kuehl, PL Bergsagel Blood, The Journal of the American Society of Hematology 92 (9), 3025-3034, 1998 | 703 | 1998 |
| Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide YX Zhu, E Braggio, CX Shi, LA Bruins, JE Schmidt, S Van Wier, XB Chang, ... Blood, The Journal of the American Society of Hematology 118 (18), 4771-4779, 2011 | 696 | 2011 |
| Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013 JR Mikhael, D Dingli, V Roy, CB Reeder, FK Buadi, SR Hayman, ... Mayo Clinic Proceedings 88 (4), 360-376, 2013 | 692 | 2013 |
| Chromosome translocations in multiple myeloma PL Bergsagel, WM Kuehl Oncogene 20 (40), 5611-5622, 2001 | 653 | 2001 |
Marta ChesiAssociate Professor of Medicine, Mayo Clinic在 mayo.edu 的电子邮件经过验证
